AEMPS — authorised 8 February 2018
- Marketing authorisation holder: Novo Nordisk A/S
- Status: approved
AEMPS authorised Ozempic on 8 February 2018
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. AEMPS authorised it on 8 February 2018.
Novo Nordisk A/S holds the Spanish marketing authorisation.